Table 2.

Regression analysis in four models with age, antipsychotic drugs life time psychosis and use of mood stabilizing drugs as dependent variables

		Coef	S.E.	p value	95 % CI
Proline	Age	−1.02	2.12	0.63	−5.28–3.24
	Antipsychotic drugsb	5.15	7.03	0.47	−8.96–19.26
	Life time psychosis	−81.55	46.93	0.09	−175.81–12.72
	Gender	−78.81	42.92	0.07	−165.02–7.39
	Mood stabilizing drugs	−56.78	52.74	0.29	−162.70–49.14
Glutamate	Age	0.80	0.32	.018*	0.14–1.46
	Antipsychotic drugsb	2.07	1.01	.046*	0.04–4.10
	Life time psychosis	−6.68	6.94	0.34	−20.71–7.35
	Gender	−11.18	6.64	0.10	−24.95–−2.25
	Mood stabilizing drugs	3.29	8.03	0.68	−12.95–19.52
Glutamine	Age	−1.18	1.10	0.29	−3.40–1.04
	Antipsychotic drugsb	3.06	3.41	0.38	−3.84–9.95
	Life time psychosis	14.17	23.50	0.55	−33.37–61.72
	Gender	−65.17	22.50	0.006*	−110.53–−19.51
	Mood stabilizing drugs	68.17	27.19	0.016*	13.17–123.18
Ratio Gln/Glu	Age	−0.14	0.06	0.003*	−0.27–−0.02
	Antipsychotic drugsb	−0.19	0.19	0.34	−0.58–0.21
	Life time psychosis	1.07	1.35	0.43	−1.65–3.79
	Gender	1.43	1.29	0.28	−1.18–4.03
	Mood stabilizing drugs	2.06	1.56	0.19	−1.09–5.12

*p ≤ 0.05

^bIn haloperidol equivalents